Searched for
KEYTRUDA SALES INCREASE
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Nasdaq big crash today: Nasdaq falls over 400 points, wipes out $1.1 trillion as AI stocks tumble — why AI shares are fallingNasdaq big crash today: Nasdaq falls over 400 points as AI stocks tumble. The Nasdaq Composite crashed 422.49 points today. This 1.79% drop...
- US stock market crashes today: Why Nasdaq, S&P 500 and Dow Jones all turned red – Gold and silver surge as investors rotate into safetyUS stock market crashes today: Nasdaq, S&P 500, Dow fall as gold and silver rally on investor fear. The Nasdaq Composite plunged 1.01% to 2...
- What’s powering Mounjaro’s rise to the top of Indian drug marketMounjaro has made a splash in Indian healthcare, emerging as the go-to solution for both diabetes management and weight loss. This remarkab...
- Is US stock market down today? Why is the US stock market crashing today — S&P 500 and Nasdaq fall big while Dow Jones gainsUS stock market today live update analysis news: The S&P 500 fell 0.3% to 5,018. Nasdaq sank 0.6% to 15,170 as Meta plunged 11% after weak ...
- Merck to cut jobs and costs as demand for Gardasil in China remains weakMerck & Co revealed job and cost reductions to save $3 billion annually. This decision followed lower second-quarter results. Weak demand f...
- Dr Reddy’s, Alvotech to co-develop Keytruda biosimilarDr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a high...
- Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatmentDr. Reddy's Laboratories has partnered with Alvotech to co-develop and commercialize a biosimilar for pembrolizumab (Keytruda), a crucial c...
- Dr Reddy’s shares climb over 4% after Keytruda biosimilar deal with AlvotechDr. Reddy’s shares rose over 4% after announcing a global biosimilar partnership with Alvotech for Keytruda. Q4FY25 profit rose 22% YoY to ...
- Will Biocon's foray into biosimilar boost its bottomline?Biological drugs are harvested from living organisms or certain components of living organisms. These drugs are very specific and highly ef...
Load More
